Stay updated on DETERMINE-preserved: Dapagliflozin Clinical Trial
Sign up to get notified when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.

Latest updates to the DETERMINE-preserved: Dapagliflozin Clinical Trial page
- Check4 days agoChange DetectedUpdated the Italian site entry from Napoli, Italy, 80131 to Naples, Italy, 80131 to reflect English naming.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision: v3.5.0 label updated on the page, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check18 days agoChange DetectedFooter revision tag updated from v3.4.2 to v3.4.3. No changes to study details, results, or navigation.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedPage revision updated to v3.4.2, replacing the prior v3.4.1 notice about government funding; no trial content or data is changed.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded a government funding notice banner at the top of the page and updated to revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded a glossary toggle display; updated footer labels with capitalization changes (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and bumped the revision to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to DETERMINE-preserved: Dapagliflozin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.